Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ramnik Xavier, M.B.,B.Ch.

Co-Author

This page shows the publications co-authored by Ramnik Xavier and John Garber.
Connection Strength

0.699
  1. Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases. . 2017 May 10; 21(5):603-610.e3.
    View in: PubMed
    Score: 0.182
  2. Alterations in Fecal Microbiomes and Serum Metabolomes of Fatigued Patients With Quiescent Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2021 03; 19(3):519-527.e5.
    View in: PubMed
    Score: 0.056
  3. Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis. Cell. 2019 07 25; 178(3):714-730.e22.
    View in: PubMed
    Score: 0.053
  4. Genetic Markers Predict Primary Nonresponse and Durable Response to Anti-Tumor Necrosis Factor Therapy in Ulcerative Colitis. Inflamm Bowel Dis. 2018 07 12; 24(8):1840-1848.
    View in: PubMed
    Score: 0.049
  5. Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases. J Crohns Colitis. 2018 Apr 27; 12(5):525-531.
    View in: PubMed
    Score: 0.049
  6. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Med. 2017 Nov 28; 9(1):103.
    View in: PubMed
    Score: 0.047
  7. Genetic risk factors for serious infections in inflammatory bowel diseases. Scand J Gastroenterol. 2017 May; 52(5):570-576.
    View in: PubMed
    Score: 0.045
  8. Erratum to: Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases. Dig Dis Sci. 2017 02; 62(2):552.
    View in: PubMed
    Score: 0.045
  9. Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease. Inflamm Bowel Dis. 2017 01; 23(1):82-88.
    View in: PubMed
    Score: 0.045
  10. Genetic Markers Predict Primary Non-Response and Durable Response To Anti-TNF Biologic Therapies in Crohn's Disease. Am J Gastroenterol. 2016 12; 111(12):1816-1822.
    View in: PubMed
    Score: 0.044
  11. Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations: A Cohort Study. Inflamm Bowel Dis. 2016 09; 22(9):2149-57.
    View in: PubMed
    Score: 0.043
  12. Body Mass Index, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease. Inflamm Bowel Dis. 2015 Oct; 21(10):2304-2310.
    View in: PubMed
    Score: 0.041
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.